Cargando…

Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy

BACKGROUND: Surgery is the only way to cure gastric adenocarcinoma (GAC), and chemotherapy is the basic adjuvant management for GAC. A significant prognostic nomogram for predicting the respective disease-specific survival (DSS) rates of GAC patients who receive surgery and chemotherapy has not been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chao-Yang, Yang, Jin, Zi, Hao, Zheng, Zhong-Li, Li, Bing-Hui, Wang, Yang, Ge, Zheng, Jian, Guang-Xu, Lyu, Jun, Li, Xiao-Dong, Ren, Xue-Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943892/ https://www.ncbi.nlm.nih.gov/pubmed/31906882 http://dx.doi.org/10.1186/s12885-019-6495-2

Ejemplares similares

Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy
por: Wang, Jin, et al.
Publicado: (2020)

A Nomogram for Predicting Risk of Thromboembolism in Gastric Cancer Patients Receiving Chemotherapy
por: Yuan, Hai-Liang, et al.
Publicado: (2021)

Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy
por: Hu, Bing, et al.
Publicado: (2023)

Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy
por: Ma, Tai, et al.
Publicado: (2019)

An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy
por: Qi, Lishuang, et al.
Publicado: (2016)

A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma
por: Wang, Na, et al.
Publicado: (2020)

Development of nomograms for predicting the survival of intestinal-type gastric adenocarcinoma patients after surgery
por: Liu, Chu-Yun, et al.
Publicado: (2023)

A Modified ypTNM Staging System–Development and External Validation of a Nomogram Predicting the Overall Survival of Gastric Cancer Patients Received Neoadjuvant Chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

A novel nomogram for predicting survival of patients with poorly differentiated gastric adenocarcinoma
por: Zhou, Xiaolu, et al.
Publicado: (2021)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)

Prognostic factors influencing the survival of patients with carcinoma of the gastric cardia receiving preoperative interventional embolization chemotherapy
por: Cao, Hai-Li, et al.
Publicado: (2017)

Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy
por: Gou, Miaomiao, et al.
Publicado: (2022)

MAP3K1 rs889312 genotypes influence survival outcomes of Chinese gastric cancer patients who received adjuvant chemotherapy based on platinum and fluorouracil regimes
por: Yang, Jian, et al.
Publicado: (2019)

A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma
por: Xie, Yangyang, et al.
Publicado: (2023)

A prognostic nomogram for pancreatic ductal adenocarcinoma patients’ all-cause survival in a Surveillance, Epidemiology, and End Results analysis
por: Li, Chengzhuo, et al.
Publicado: (2020)

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
por: Wang, Jiao, et al.
Publicado: (2020)

Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)

Author Correction: Development of nomograms for predicting the survival of intestinal-type gastric adenocarcinoma patients after surgery
por: Liu, Chu-Yun, et al.
Publicado: (2023)

Incorporation of liver chemistry score in predicting survival of liver‐involved advanced gastric cancer patients who received palliative chemotherapy
por: Feng, Ying, et al.
Publicado: (2022)

Construction and validation of a novel nomogram to predict cancer-specific survival in patients with gastric adenocarcinoma
por: Nie, Guole, et al.
Publicado: (2023)

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy
por: Ma, Xiaolu, et al.
Publicado: (2022)

Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab
por: Custodio, A, et al.
Publicado: (2017)

A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment
por: Wei, Ying-Hong, et al.
Publicado: (2022)

The Effectiveness of RECIST on Survival in Patients with NSCLC Receiving Chemotherapy with or without Target Agents as First-Line Treatment
por: Zhou, Ting, et al.
Publicado: (2015)

Residual Volume of Lymph Nodes During Chemoradiotherapy Based Nomogram to Predict Survival of Nasopharyngeal Carcinoma Patient Receiving Induction Chemotherapy
por: Li, Yan, et al.
Publicado: (2021)

A nomogram to predict survival probability of gastric cancer patients undergoing radical surgery and adjuvant chemotherapy
por: Ma, Ling, et al.
Publicado: (2022)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
por: Wu, Jia-Lin, et al.
Publicado: (2023)

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab
por: Wang, Lize, et al.
Publicado: (2021)

Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery
por: Guo, Zhenjiang, et al.
Publicado: (2022)

Dynamic Nomogram for Predicting Long-Term Survival in Terms of Preoperative and Postoperative Radiotherapy Benefits for Advanced Gastric Cancer
por: Li, Xinghui, et al.
Publicado: (2023)

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
por: Tian, Yuan, et al.
Publicado: (2021)

Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery
por: Chen, Yonghe, et al.
Publicado: (2021)

A novel nomogram based on cardia invasion and chemotherapy to predict postoperative overall survival of gastric cancer patients
por: Mo, Hanjun, et al.
Publicado: (2021)

Effects of Radiotherapy on Survival of Esophageal Cancer Patients Receiving Immunotherapy: Propensity Score Analysis and Nomogram Construction
por: Nie, Yuanliu, et al.
Publicado: (2022)

Assessment of Survival of Pediatric Patients With Hepatoblastoma Who Received Chemotherapy Following Liver Transplant or Liver Resection
por: Feng, Jincheng, et al.
Publicado: (2019)

Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma
por: Guo, Ming gao, et al.
Publicado: (2014)

Protein-bound polysaccharide K prolonged overall survival in gastric cancer patients from a non-Japanese Asian country who received gastrectomy and adjuvant chemotherapy
por: Wang, Ting-Yao, et al.
Publicado: (2022)

Construction and validation of a nomogram model to predict the overall survival rate of esophageal cancer patients receiving neoadjuvant chemotherapy: A population-based study
por: Yang, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2j1ckctg8t4jhl99blikr3j9h0